DUSA Pharmaceuticals to End Skin Drug Deal With GlaxoSmithKline's Stiefel Laboratories
Reuters -- DUSA Pharmaceuticals Inc (DUSA.O) sought to terminate an agreement with a unit of GlaxoSmithKline PLC (GSK.L) to market and distribute its drug to treat scaly patches on the skin, in Latin America.